After waiting for a long time, especially due to courts shutting down around the United States because of the COVID-19 pandemic, it seems Zantac plaintiffs in California will finally have their day in court. However, they have to wait a year before the proceedings commence. According to a news report, a state court judge scheduled the first Zantac trial in California to begin on October 10th, 2022.
The report noted that while Zanatc trials in other states may begin before October, the Zantac trial in California is the first one with a fixed date. Several litigants across the United States filed lawsuits against the makers of the Ranitidine drug. The medication helps to reduce stomach acid production.
Aside from California, Zantac lawsuits are pending in Illinois (Cook County), Minnesota (Minneapolis), New Jersey, New York, Oregon (Portland), Pennsylvania (Philadelphia), and Washington (Seattle). There is also a case before the U.S. District Court Judge Robin L. Rosenberg for the Southern District of Florida.
The California trial will take place before Judge Grillo of the Superior Court of Alameda. The plaintiffs will choose the first case to go the rail, with the defendants having the second option. The lawsuits against Zantac stem from those who used the drug linking it to cancer. Some cancers linked to the Ranitidine medication are bladder cancer, prostate cancer, breast cancer, stomach cancer, pancreatic cancer, etc.
The plaintiffs’ case is based on the allegation that the ranitidine product is contaminated with NDMA, a probable human carcinogen. The Zantac lawsuit is one out of many product liability claims that different Big Pharma manufacturers are facing. To file a lawsuit or join an existing class action, you must meet certain requirements.
Contact our mass tort lawyers to learn whether you meet the requirement.